News & Updates

A single injection of tocilizumab is enough to weaken systemic inflammation for up to 7 days in patients with the coronavirus disease 2019 (COVID-19), a recent study suggests.

The coverage of influenza vaccination for Medicare beneficiaries remains poor, reports a study, noting missed opportunities despite availability of vaccines with no copayment. In addition, there are still disparities in vaccination uptake by race/ethnicity.

Adults newly diagnosed with COVID-19 in outpatient settings and enrolled in an automated remote monitoring service are less likely to succumb to the disease potentially due to more frequent telemedicine encounters and earlier presentation to the emergency department (ED), a study has shown.

Estimated pulse wave velocity (ePWV) is significantly associated with mean systolic (SBP) and mean diastolic blood pressure (DBP), with an increase in ePWV resulting in a higher incidence of hypertension, reports a recent study.

Low-intensity focused ultrasound can be delivered to the target zone in patients with drug-resistant epilepsy without significant adverse events, as shown in a phase I study. Moreover, the treatment produces meaningful changes in stereo-electroencephalography activity.

In patients with the coronavirus disease 2019 (COVID-19), hypertension aggravates the risk of cardiac injury and severe disease phenotype, a recent study has found.